Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05928247 · ClinicalTrials.gov registry record · NA
Manualized Assessment and Treatment Model of Challenging Behavior
A NA study of Aggression and Problem Behavior, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05928247: Recruiting NA study of Aggression and Problem Behavior, sponsored by Rutgers, The State University of New Jersey.
NCT05928247 is a NA study of Aggression and Problem Behavior that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 30 participants, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05928247, a NA study of Aggression and Problem Behavior, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Despite decades of mounting single-case-design evidence for the efficacy of applied behavior analysis (ABA) and other approaches for the assessment and treatment of challenging behavior, an evidence-based comprehensive approach remains to exist. The current study will collect test the efficacy of a standardized manual for assessing and treating challenging behavior for individuals with severe and mild challenging behavior.
Primary Outcome
The investigators will collect continuous, direct-observation measures of destructive behavior throughout all phases of the study. They will compare rates of destructive behavior during assessment, treatment, caregiver training, and followup.
Conditions Studied
Interventions
- BEHAVIORAL Functional Communication Training (FCT)
- BEHAVIORAL Non-Contingent Reinforcement (NCR)
- BEHAVIORAL Competing Items and Response Blocking
- BEHAVIORAL Research Units in Behavioral Intervention (RUBI) protocol
Study Locations (1)
New Jersey
- Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services - Somerset
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-01-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05928247 shows while recruiting
NCT05928247 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 154-participant average among 21 other Aggression trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Aggression appearing as the primary indexed condition, and to 4 interventions - of which Functional Communication Training (FCT) is the first listed.
NCT05928247 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT05928247 about?
NCT05928247 is a clinical study titled "Manualized Assessment and Treatment Model of Challenging Behavior". Despite decades of mounting single-case-design evidence for the efficacy of applied behavior analysis (ABA) and other approaches for the assessment and treatment of challenging behavior, an evidence-based comprehensive approach remains to exist. The current study will collect test the efficacy of a ...
What is the current status of trial NCT05928247?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-01-30. Estimated completion is 2026-12-31.
What conditions does trial NCT05928247 study?
This clinical trial studies the following conditions: Aggression, Problem Behavior, Self-Injury.
What interventions are being tested in trial NCT05928247?
The interventions under investigation include: Functional Communication Training (FCT) (BEHAVIORAL), Non-Contingent Reinforcement (NCR) (BEHAVIORAL), Competing Items and Response Blocking (BEHAVIORAL), Research Units in Behavioral Intervention (RUBI) protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT05928247?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05928247 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05928247's enrollment target sits among peer trials
30 17th of 21 higher than 3 of 21 other Aggression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aggression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Treatment of Chronic Anger and Aggression Following Military-Related Betrayal
RECRUITING · NA
-
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
RECRUITING · NA
-
Basic and Applied Research on Extinction Bursts
RECRUITING · NA
-
Just-In-Time Intervention to Reduce Alcohol-Facilitated Intimate Partner Violence Perpetration
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI